Sort
46,585 grants matching “heart failure”
Novel sphingolipid metabolites in myocardial ischemia
$388,125Lauren Ashley Cowart · Virginia Commonwealth University · R01 · FY2020 · HL
Novel sphingolipid metabolites in myocardial ischemia
$388,125Lauren Ashley Cowart · Virginia Commonwealth University · R01 · FY2024 · HL
Mechanisms of corticosteroids in dystrophic cardiomyopathy
$388,125Christopher Ryan Heier · Virginia Commonwealth University · R01 · FY2024 · HL
Novel sphingolipid metabolites in myocardial ischemia
$388,125Lauren Ashley Cowart · Virginia Commonwealth University · R01 · FY2023 · HL
Unconventional IL-1 signaling in heart failure
$388,125Stefano Toldo · Virginia Commonwealth University · R01 · FY2022 · HL
Unconventional IL-1 signaling in heart failure
$388,125Antonio Abbate · Virginia Commonwealth University · R01 · FY2021 · HL
Relaxin Signaling in Post-MI Cardiac Inflammation, Adverse Remodeling and Failure
$388,125Fadi N Salloum · Virginia Commonwealth University · R01 · FY2019 · HL
Birth Defects: Moebius syndrome and related facial weakness disorders
$388,120Ethylin Wang Jabs · Icahn School Of Medicine At Mount Sinai · U01 · FY2014 · HD
Chaperone-Mediated Autophagy in Normal Cardiac Biology and Heart Failure
$388,100Richard N Kitsis · Albert Einstein College Of Medicine · R01 · FY2018 · HL
Ca & InsP3 Receptor Signaling in Cardiac Myocytes
$388,088Lothar A Blatter · University Of California At Davis · P01 · FY2010 · HL
Molecular Mechanisms of Heart Regeneration
$388,080Ching-Ling E Lien · Children'S Hospital Of Los Angeles · R01 · FY2014 · HL
The optimal loop diuretic: mechanistic insights from longitudinal changes in blood and urine proteins to explain efficacy and safety of torsemide vs furosemide after a heart failure hospitalization
$388,080Lauren Beth Cooper · Inova Health Care Services · R01 · FY2022 · HL
Mechanisms of Telomere-Mediated Lung Disease
$388,069Jonathan K. Alder · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · HL
Identifying the Causes of the Stagnation in National U.S. Cardiovascular Disease Mortality
$388,068Neil Mehta · University Of Texas Med Br Galveston · R01 · FY2023 · AG
Altered CNS intercellular signaling mechanisms in cardiovascular disease
$388,056Javier E Stern · Augusta University · R01 · FY2008 · HL
Cardiovasology
$388,048Andre Terzic · Mayo Clinic Rochester · T32 · FY2015 · HL
Regulation of lipolysis by mTORC1
$388,044Konstantin V. Kandror · Boston University Medical Campus · R01 · FY2019 · DK
The effect of voluntary bundled payments on vulnerable populations
$388,036Amol S Navathe · University Of Pennsylvania · R01 · FY2024 · HS
A cell-permeable peptide therapeutic to reduce myocardial reperfusion injury
$388,036Lucas Shores · Laborecom Therapeutics Inc. · R43 · FY2025 · HL
Proteasomal Degradation of XPB as a Novel Mechanism for Treating Inflammation
$388,035Jason Elinoff · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Biomaterial Platforms to Model the Role of Mechanical Overload in MYBPC3-Linked Hypertrophic Cardiomyopathy
$388,000Nathaniel Huebsch · Washington University · R01 · FY2021 · HL
Molecular Mechanisms of Myofilament Dysfunction in Heart Failure
$388,000Pieter P. De Tombe · University Of Illinois At Chicago · P01 · FY2010 · HL
The methyltransferase Smyd1 regulates cardiac physiology
$388,000Sarah Franklin · University Of Utah · R01 · FY2023 · HL
iPhone Helping Evaluate Atrial Fibrillation Rhythm through Technology (iHEART)
$388,000Kathleen T Hickey · Columbia University Health Sciences · R01 · FY2015 · NR
Checkpoint functions, lifespan determination and neurodegeneration (3 of 11)
$388,000Gordon J. Lithgow · Buck Institute For Research On Aging · RL1 · FY2007 · ES